FOLH1 and posterior cortical atrophy: In an effort to identify potential immunotherapeutic targets for the treatment of PCa with CAR T-cells, three antigens, namely Prostate-specific membrane antigen (PSMA), Prostate stem cell antigen (PSCA) and Epithelial cell adhesion molecule (EpCam CD326), are currently of clinical interest and part of clinical studies.